Placental Growth Factor Levels in Quadriceps Muscle Are Reduced by a Western Diet in Association With Advanced Glycation End Products.
Placental Growth Factor Levels in Quadriceps Muscle Are Reduced by a Western Diet in Association With Advanced Glycation End Products.
复制标题
DOI:
10.1152/ajpheart.00511.2018
复制
发表时间:
2019-10
期刊:
影响因子:
--
通讯作者:
Asitha T. Silva;F. Rouf;Oluwayemisi A. Semola;M. Payton;Pamela C. Lovern
中科院分区:
文献类型:
--
作者:
Asitha T. Silva;F. Rouf;Oluwayemisi A. Semola;M. Payton;Pamela C. Lovern
In peripheral artery disease (PAD), atherosclerotic occlusion chronically impairs limb blood flow. Arteriogenesis (collateral artery remodeling) is a vital adaptive response to PAD that protects tissue from ischemia. Type II diabetics have a high risk of developing PAD, and would benefit from arteriogenesis. However, arteriogenesis is suppressed in diabetics by a multifaceted mechanism which remains incompletely defined. Upregulation of placental growth factor (PLGF) is a key early step in arteriogenesis. Therefore, we hypothesized that metabolic dysfunction would impair PLGF expression in skeletal muscle. We tested this hypothesis in C57BL/6J and ApoE-/- mice of both sexes fed a Western diet (WD) for 24 wk. We first assessed baseline levels of PLGF, vascular endothelial growth factor (VEGF-A), and VEGF receptor 1 (VEGFR-1) protein in hindlimb skeletal muscle. Only PLGF was consistently decreased by the WD. We next investigated the effect of 24 wk of the WD on the response of PLGF, VEGF-A, VEGFR1, and monocyte chemoattractant protein-1 (MCP-1) to the physiological stimulus of vascular occlusion. Hindlimb ischemia was induced in mice by gradual femoral artery occlusion using an ameroid constrictor. Growth factor levels were measured 3-28 d post-surgery. In C57BL/6J mice, the WD decreased and delayed upregulation of PLGF, and abolished upregulation of VEGF-A and VEGFR-1, but had no effect on MCP-1. In ApoE-/- mice fed either diet, all factors tested failed to respond to occlusion. Metabolic phenotyping of mice and in vitro studies suggest that an advanced glycation end product (AGE)/TNFα-mediated mechanism could contribute to the effects observed in vivo.